Can Leads Biolabs turn Opamtistomig into a frontline EP-NEC treatment contender?
EP-NEC has no approved drug worldwide. Leads Biolabs now has to prove Opamtistomig can turn rare-tumor urgency into regulatory momentum.
Pharma & Biotech